Skip to content
LexBuild

Board of Scientific Counselors, National Center for Infectious Diseases: Meeting

---
identifier: "/us/fr/01-29338"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Board of Scientific Counselors, National Center for Infectious Diseases: Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "01-29338"
section_name: "Board of Scientific Counselors, National Center for Infectious Diseases: Meeting"
positive_law: false
currency: "2001-11-26"
last_updated: "2001-11-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-29338"
document_type: "notice"
publication_date: "2001-11-26"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "66 FR 59022"
fr_volume: 66
---

#  Board of Scientific Counselors, National Center for Infectious Diseases: Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting.

*Name:* Board of Scientific Counselors, National Center for Infectious Diseases (NCID).

*Time and Date:* 8:30 a.m.-3:30 p.m., December 6, 2001.

*Place:* CDC, Auditorium B, Building 1, Clifton Road, Atlanta, Georgia 30333.

*Status:* Open to the public, limited only by the space available.

*Purpose:* The Board of Scientific Counselors, NCID, provides advice and guidance to the Director, CDC, and Director, NCID, in the following areas: program goals and objectives; strategies; program organization and resources for infectious disease prevention and control; and program priorities.

*Matters to be Discussed:* Agenda items will include:

1. Opening Session: NCID Update

a. Institute of Medicine

b. Global Strategy

c. Budget

2. Program Update:

a. West Nile

b. Dengue

c. Influenza

d. Malaria

e. Creutzfeldt-Jakob Disease

3. Bioterrorism Updates and Discussion

a. Organizational Approach/Structure

b. Anthrax Investigations

c. Smallpox Activities

d. Other issues, e.g., antimicrobial resistance/widespread use of antibiotics

4. Board meets with Director, CDC

5. Discussions and Recommendations Other agenda items include announcements/introductions; follow-up on actions recommended by the Board May 2001; consideration of future directions, goals, and recommendations.

Agenda items are subject to change as priorities dictate.

An unavoidable administrative delay prevented meeting the 15-day publication requirement.

Written comments are welcome and should be received by the contact person listed below prior to the opening of the meeting.

*Contact Person For More Information:* Diane S. Holley, Office of the Director, NCID, CDC, Mailstop C-19, 1600 Clifton Road, NE, Atlanta, Georgia 30333, email *[email protected];* telephone 404/639-0078.

The Director, Management Analysis and Services office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: November 15, 2001.

John Burckhardt,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.